Stereotaxis Inc (STXS)

$2.19 -0.14 (-6.01%)
Market Cap 217.45M
Revenue (ttm) 26.92M
Net Income (ttm) -24.05M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -89.34%
Debt to Equity Ratio 0.00
Volume 841,700
Avg Vol 506,580
Day's Range N/A - N/A
Shares Out 93.33M
Stochastic %K 2%
Beta 1.44
Analysts Strong Sell
Price Target $4.20

Company Profile

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is design...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 314 678 6100
Address:
710 North Tucker Boulevard, Suite 110, Saint Louis, United States
Stonksman16
Stonksman16 Jan. 30 at 8:49 PM
$STXS Bumboclot
0 · Reply
alexpitti
alexpitti Jan. 30 at 8:26 PM
Remember when bullish posts om $STXS 3 weeks ago. Stock down 20% quickly
0 · Reply
TonySoprano1987
TonySoprano1987 Jan. 30 at 1:09 PM
$STXS back to sub $2 and EOY $3 again? trading range?!
1 · Reply
Jack90
Jack90 Jan. 29 at 9:56 PM
$STXS $SMH Double Triple orders scam to hype
0 · Reply
Eddypgil
Eddypgil Jan. 29 at 8:34 PM
$STXS priced as if company was going to have to raise $20 million,
1 · Reply
jb06000
jb06000 Jan. 29 at 7:53 PM
$STXS China is building AI hospitals. Trump next investment is right here.
0 · Reply
trigger_finger
trigger_finger Jan. 29 at 7:50 PM
$STXS On a glum day here is some optimism, and might be who is getting that US Genesis X: Dr. Francis Marchlinski (University of Pennsylvania): One of the world’s most cited EPs, he has publicly stated that "challenging infrastructure demands" were the primary barrier to adoption for physicians who were already interested in the clinical benefits of Genesis. His public support suggests a "bottlenecked" demand that the new design is intended to release. Dr. Tamas Szili-Torok (Netherlands and Hungary) - performed 6 ablations in 1 day off a Genesis. Average is 2 (1 -3). Look at the Time break-down below with Sweep. Significant change. This alone will be selling point.
2 · Reply
zbenz
zbenz Jan. 29 at 6:24 PM
$STXS This company reminds me of when I owned a cool little Saab in the 90's and lived in rural VT. I couldnt get parts for it so i sold and bought a Ford pick up. Makes me wonder what hospitals might be thinking ....key supplier risk ??? especially considering the wake ofJNJ catheter ...uphill battle for sure !
0 · Reply
jacksonjohn750
jacksonjohn750 Jan. 29 at 5:42 PM
$STXS cooked
0 · Reply
trigger_finger
trigger_finger Jan. 29 at 4:06 PM
$STXS Looks like someone has had it. 66k+ shares at 10:57. I will be picking some more up, but not yet.
0 · Reply
Latest News on STXS
Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

Jan 6, 2026, 8:01 AM EST - 24 days ago

Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference

Nov 24, 2025, 8:58 AM EST - 2 months ago

Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference

Stereotaxis, Inc. (STXS) Q3 2025 Earnings Call Transcript

Nov 11, 2025, 7:51 PM EST - 2 months ago

Stereotaxis, Inc. (STXS) Q3 2025 Earnings Call Transcript

Stereotaxis Reports 2025 Third Quarter Financial Results

Nov 11, 2025, 4:01 PM EST - 2 months ago

Stereotaxis Reports 2025 Third Quarter Financial Results

GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance

Nov 10, 2025, 4:05 PM EST - 2 months ago

GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance

Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025

Oct 21, 2025, 9:00 AM EDT - 3 months ago

Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025

Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs

Oct 15, 2025, 7:32 AM EDT - 3 months ago

Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs

Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias

Oct 13, 2025, 7:34 AM EDT - 3 months ago

Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias

Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System

Sep 22, 2025, 7:56 AM EDT - 4 months ago

Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System

First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter

Sep 2, 2025, 8:08 AM EDT - 5 months ago

First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter

Stereotaxis to Present at Upcoming Investor Conferences

Sep 2, 2025, 7:51 AM EDT - 5 months ago

Stereotaxis to Present at Upcoming Investor Conferences

Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025

Aug 28, 2025, 7:47 AM EDT - 5 months ago

Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025

Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 1:24 PM EDT - 6 months ago

Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript

Stereotaxis Reports 2025 Second Quarter Financial Results

Aug 7, 2025, 4:01 PM EDT - 6 months ago

Stereotaxis Reports 2025 Second Quarter Financial Results

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

Jul 28, 2025, 7:48 AM EDT - 6 months ago

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 23, 2025, 8:00 AM EDT - 6 months ago

Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025

Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock

Jul 17, 2025, 8:32 AM EDT - 7 months ago

Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock

Stereotaxis: Recurring Revenue Inflection

Jul 6, 2025, 2:13 AM EDT - 7 months ago

Stereotaxis: Recurring Revenue Inflection

First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology

Jul 1, 2025, 9:00 AM EDT - 7 months ago

First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology

Stereotaxis, Inc. (STXS) Q1 2025 Earnings Call Transcript

May 12, 2025, 7:04 PM EDT - 9 months ago

Stereotaxis, Inc. (STXS) Q1 2025 Earnings Call Transcript

Stereotaxis Reports 2025 First Quarter Financial Results

May 12, 2025, 4:01 PM EDT - 9 months ago

Stereotaxis Reports 2025 First Quarter Financial Results

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

Apr 22, 2025, 7:00 AM EDT - 10 months ago

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025

Apr 21, 2025, 8:00 AM EDT - 10 months ago

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program

Mar 19, 2025, 8:01 AM EDT - 11 months ago

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program

Stereotaxis to Present at 37th Annual Roth Conference

Mar 10, 2025, 8:02 AM EDT - 11 months ago

Stereotaxis to Present at 37th Annual Roth Conference

Stereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash Burn

Mar 7, 2025, 9:10 AM EST - 11 months ago

Stereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash Burn

Stereotaxis, Inc. (STXS) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 10:34 AM EST - 11 months ago

Stereotaxis, Inc. (STXS) Q4 2024 Earnings Call Transcript

Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery

Mar 3, 2025, 7:32 AM EST - 11 months ago

Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery

Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance

Mar 3, 2025, 7:31 AM EST - 11 months ago

Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance

Stereotaxis Reports 2024 Full Year Financial Results

Mar 3, 2025, 7:30 AM EST - 11 months ago

Stereotaxis Reports 2024 Full Year Financial Results

Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference

Feb 25, 2025, 8:03 AM EST - 1 year ago

Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference

Stock Market Sleeps On Stereotaxis MAGiC CE Mark

Feb 14, 2025, 10:41 AM EST - 1 year ago

Stock Market Sleeps On Stereotaxis MAGiC CE Mark

Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Feb 3, 2025, 4:05 PM EST - 1 year ago

Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Stereotaxis Announces First GenesisX Robotic System Order

Jan 30, 2025, 8:09 AM EST - 1 year ago

Stereotaxis Announces First GenesisX Robotic System Order

Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter

Jan 27, 2025, 8:00 AM EST - 1 year ago

Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter

Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology

Jan 14, 2025, 7:21 AM EST - 1 year ago

Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology

Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPA

Dec 9, 2024, 7:25 AM EST - 1 year ago

Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPA

Stereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems

Dec 2, 2024, 8:45 AM EST - 1 year ago

Stereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems

Stereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025

Dec 2, 2024, 5:03 AM EST - 1 year ago

Stereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025

Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference

Nov 26, 2024, 8:28 AM EST - 1 year ago

Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference

Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China

Nov 25, 2024, 8:21 AM EST - 1 year ago

Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China

Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System

Nov 20, 2024, 8:18 AM EST - 1 year ago

Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System

Stereotaxis, Inc. (STXS) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 7:03 PM EST - 1 year ago

Stereotaxis, Inc. (STXS) Q3 2024 Earnings Call Transcript

Stereotaxis Reports 2024 Third Quarter Financial Results

Nov 11, 2024, 4:02 PM EST - 1 year ago

Stereotaxis Reports 2024 Third Quarter Financial Results

Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation

Oct 21, 2024, 8:41 AM EDT - 1 year ago

Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation

Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society's HRX Congress

Sep 3, 2024, 8:53 AM EDT - 1 year ago

Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society's HRX Congress

Stereotaxis Receives CE Mark For GenesisX, Nears MAGiC Approval

Aug 25, 2024, 7:22 PM EDT - 1 year ago

Stereotaxis Receives CE Mark For GenesisX, Nears MAGiC Approval

Stereotaxis, Inc. (STXS) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 11:33 PM EDT - 1 year ago

Stereotaxis, Inc. (STXS) Q2 2024 Earnings Call Transcript

Stereotaxis Reports 2024 Second Quarter Financial Results

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Stereotaxis Reports 2024 Second Quarter Financial Results

Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX

Aug 12, 2024, 4:03 PM EDT - 1 year ago

Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX

Stonksman16
Stonksman16 Jan. 30 at 8:49 PM
$STXS Bumboclot
0 · Reply
alexpitti
alexpitti Jan. 30 at 8:26 PM
Remember when bullish posts om $STXS 3 weeks ago. Stock down 20% quickly
0 · Reply
TonySoprano1987
TonySoprano1987 Jan. 30 at 1:09 PM
$STXS back to sub $2 and EOY $3 again? trading range?!
1 · Reply
Jack90
Jack90 Jan. 29 at 9:56 PM
$STXS $SMH Double Triple orders scam to hype
0 · Reply
Eddypgil
Eddypgil Jan. 29 at 8:34 PM
$STXS priced as if company was going to have to raise $20 million,
1 · Reply
jb06000
jb06000 Jan. 29 at 7:53 PM
$STXS China is building AI hospitals. Trump next investment is right here.
0 · Reply
trigger_finger
trigger_finger Jan. 29 at 7:50 PM
$STXS On a glum day here is some optimism, and might be who is getting that US Genesis X: Dr. Francis Marchlinski (University of Pennsylvania): One of the world’s most cited EPs, he has publicly stated that "challenging infrastructure demands" were the primary barrier to adoption for physicians who were already interested in the clinical benefits of Genesis. His public support suggests a "bottlenecked" demand that the new design is intended to release. Dr. Tamas Szili-Torok (Netherlands and Hungary) - performed 6 ablations in 1 day off a Genesis. Average is 2 (1 -3). Look at the Time break-down below with Sweep. Significant change. This alone will be selling point.
2 · Reply
zbenz
zbenz Jan. 29 at 6:24 PM
$STXS This company reminds me of when I owned a cool little Saab in the 90's and lived in rural VT. I couldnt get parts for it so i sold and bought a Ford pick up. Makes me wonder what hospitals might be thinking ....key supplier risk ??? especially considering the wake ofJNJ catheter ...uphill battle for sure !
0 · Reply
jacksonjohn750
jacksonjohn750 Jan. 29 at 5:42 PM
$STXS cooked
0 · Reply
trigger_finger
trigger_finger Jan. 29 at 4:06 PM
$STXS Looks like someone has had it. 66k+ shares at 10:57. I will be picking some more up, but not yet.
0 · Reply
Forenzi
Forenzi Jan. 29 at 10:15 AM
$STXS if you have doubts-SELL! And stop waiting for someone to hold your hand.
1 · Reply
trigger_finger
trigger_finger Jan. 28 at 5:57 PM
$STXS I have said this on a few others I own, or trying to own, but this will go higher. We have time to see if Gen X will be a success or not. Investors will get more giddy when they launch at HRS, and have some additional approvals out of the way. David has also got to put everyone at ease with some more cash. If you think about their cash position (14 million headed into January) and 3 robots is probably about 4 million in materials (they have 25% margin until higher numbers). Cash burn and 3 robots is half their cash, it will be 3/4 by June (even if they are inching towards breakeven). Need to get that out of the way and you will see some money flows. This company is brand new now, with a real business. Its still speculation and should be treated as such. 4.30 coming by June imo.
2 · Reply
TonySoprano1987
TonySoprano1987 Jan. 28 at 9:21 AM
$STXS After watching the video about the production site, I have doubts about my investment here. The small building (large garage) here justifies a valuation of +250 million, with the hope that it will be valued at +500 million by the end of 2026... What do you think?
5 · Reply
Stonksman16
Stonksman16 Jan. 27 at 10:15 PM
$STXS bag holding is fun
1 · Reply
Georges8792
Georges8792 Jan. 27 at 5:25 PM
$STXS https://www.linkedin.com/posts/ep-map-it_hvexpress-enables-simultaneous-his-activity-7421963987711369217-j47w?utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
cheating_stock_investor
cheating_stock_investor Jan. 27 at 3:21 PM
$STXS you would think investors would be happy they have 3 units under production for delivery but instead they saw the production facility looks like nobody is going to work. Wtf.
3 · Reply
Ratman44
Ratman44 Jan. 27 at 12:16 AM
$STXS if you skip to the end they walk through the whole STXS production area. https://youtu.be/mWEgK7p7BNg?si=PvRDy_sCxUjPA3zk The STXS facility part starts at 13:25 or so.
1 · Reply
Georges8792
Georges8792 Jan. 26 at 4:25 AM
$STXS https://www.linkedin.com/posts/peteweissmd_magicsweep-activity-7421098143515336704-3wxE?utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_source=social_share_send&utm_campaign=share_via
1 · Reply
trigger_finger
trigger_finger Jan. 25 at 5:38 PM
$STXS Path to $4.30+ by June 2026 1. Genesis X launch financing ($14 million in the bank going into 2026, burning roughly 4.2 million a quarter). Need to put investors at ease with at least $20 million more capital, and should already be hiring sales staff(no postings yet). 2. Emagin and Synchrony/Synx approvals. 3. Magic PFA (1st Human clinical trials early Q2, would be buliish) Magic PFA would future proof hospital investment. I do not expect much revenue until 2H of 2026 from Magic, with hospitals burning through their JNJ RMN catheters. I hope I am wrong here. 2025 got share price to approx 10x revenue at $3.50 2026 should get $4.30+ would also be approx 10x revenue and lines up perfectly technically 2027 - 8 million a Q recurring, 1 Gen X sale, 2 to 3 Gen X sales gets to 13 million a quarter and 52 million in sales. $5.20 price target based on 10x revenue. Spec investment.
0 · Reply
trigger_finger
trigger_finger Jan. 22 at 3:47 PM
$STXS 1 day close over 2.85, 52 week high becomes magnet. For those that don't enjoy technical takes, shut up, go educate yourself.
1 · Reply
TonySoprano1987
TonySoprano1987 Jan. 22 at 2:41 PM
$STXS are we on a uptrend or just buy the rumour and then sell the news (approval)?
3 · Reply
cheating_stock_investor
cheating_stock_investor Jan. 21 at 9:22 PM
$STXS one thing people havent been talking about is synx cloud capability allowing remote collaboration for ep and future added indication procedures. This gives additional subscription revenue models in the future that allow them to charge storage and scalable training to rapidly deploy systems globally. This is still considered under the radar and I believe 2026 is their come out year.
1 · Reply